Trials / Sponsors / Evofem Inc.
Evofem Inc.
Industry · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection Sexually Transmitted Diseases, Gonorrhea, Chlamydia | Phase 3 | 2020-10-15 |
| Completed | Phase 2B/3 Double-blinded Placebo-controlled Chlamydia Trachomatis Infection | Phase 2 / Phase 3 | 2017-11-03 |
| Completed | AMP002 Phase III Contraceptive Study Contraception | Phase 3 | 2017-07-24 |
| Completed | Duration of Effect of Acidform Gel on Vaginal pH Healthy | Phase 1 | 2016-08-24 |
| Terminated | Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202 Central Abdominal Bulging | Phase 3 | 2015-06-01 |
| Completed | Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutane Central Abdominal Bulging | Phase 3 | 2015-04-09 |
| Completed | Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol V Contraception | Phase 3 | 2011-04-01 |